BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21827889)

  • 1. Immune-mediated acquired ataxias.
    Hadjivassiliou M
    Handb Clin Neurol; 2012; 103():189-99. PubMed ID: 21827889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.
    Hadjivassiliou M
    CNS Neurol Disord Drug Targets; 2019; 18(6):423-431. PubMed ID: 29268693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune-Mediated Cerebellar Ataxias].
    Mitoma H
    Brain Nerve; 2021 May; 73(5):611-619. PubMed ID: 34006695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
    Mitoma H; Manto M; Hampe CS
    Curr Neuropharmacol; 2019; 17(1):33-58. PubMed ID: 30221603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical presentation of immune mediated cerebellar ataxia].
    Honnorat J; Trouillas P
    Rev Neurol (Paris); 2003 Jan; 159(1):11-22. PubMed ID: 12618649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Ataxias: The Continuum of Latent Ataxia, Primary Ataxia and Clinical Ataxia.
    Manto M; Mitoma H
    J Integr Neurosci; 2024 Apr; 23(4):79. PubMed ID: 38682229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.
    Mitoma H; Manto M; Hadjivassiliou M
    J Mov Disord; 2021 Jan; 14(1):10-28. PubMed ID: 33423437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune-Mediated Cerebellar Ataxias].
    Mitoma H
    Brain Nerve; 2023 Jun; 75(6):737-747. PubMed ID: 37287357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism & related disorders. Ataxias.
    Klockgether T
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S391-4. PubMed ID: 18267270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.
    Mitoma H; Adhikari K; Aeschlimann D; Chattopadhyay P; Hadjivassiliou M; Hampe CS; Honnorat J; Joubert B; Kakei S; Lee J; Manto M; Matsunaga A; Mizusawa H; Nanri K; Shanmugarajah P; Yoneda M; Yuki N
    Cerebellum; 2016 Apr; 15(2):213-32. PubMed ID: 25823827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated ataxias.
    Joubert B; Rostásy K; Honnorat J
    Handb Clin Neurol; 2018; 155():313-332. PubMed ID: 29891069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and management of rapid-onset gluten ataxias: case series.
    Newrick L; Hoggard N; Hadjivassiliou M
    Cerebellum Ataxias; 2021 Jun; 8(1):16. PubMed ID: 34120658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.
    Hadjivassiliou M; Manto M; Mitoma H
    Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated ataxias: Guide to clinicians.
    Meira AT; de Moraes MPM; Ferreira MG; Franklin GL; Rezende Filho FM; Teive HAG; Barsottini OGP; Pedroso JL
    Parkinsonism Relat Disord; 2023 Dec; 117():105861. PubMed ID: 37748994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatable Ataxias: How to Find the Needle in the Haystack?
    Stezin A; Pal PK
    J Mov Disord; 2022 Sep; 15(3):206-226. PubMed ID: 36065614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies.
    Piccolo G; Tavazzi E; Cavallaro T; Romani A; Scelsi R; Martino G
    J Neurol Sci; 2010 Mar; 290(1-2):148-9. PubMed ID: 20056249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
    Mitoma H; Nanri K
    Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.